Literature DB >> 6693074

Extrahepatic biliary atresia.

D Alagille.   

Abstract

Extrahepatic biliary atresia is defined as partial or total absence of permeable bile duct between porta hepatis and the duodenum. The incidence varies from 1:8,000 to 1:10,000. Cholestasis is total and permanent. 131I Rose Bengal test and needle liver biopsy allow correct identification of 95% of cases before surgery. Before the surgical procedure described by Kasai in 1959, all patients died between 1 and 2 years of age. Through the use of different types of Kasai's procedures by experienced groups, 30 to 35% of patients are successfully operated on. In our group, 248 infants underwent surgery, 121 before 1977: 44 (36.6%) are alive at least 5 years after surgery. Growth is within normal limits in all children still alive, even in those who presented with numerous and severe episodes of cholangitis during the first two postoperative years. Portal hypertension was progressive in 23 children with splenomegaly and esophageal varices developing between 1 and 2 years of age. Five patients bled profusely between 2 and 4 years of age: portal systemic shunts were performed in 4. Surgical liver biopsies were performed in 20 children, 5 to 8 years old: cirrhosis was present in all and was micronodular in 13 and macronodular in 7. The most impressive histologic change was absence of biliary ducts or ductules. This histologic finding can be related with percutaneous transhepatic cholangiographic pictures. Despite the abnormal appearance of intrahepatic bile ducts and the constant presence of cirrhosis with portal hypertension, all 44 patients who are alive at least 5 years after surgery seem to lead almost normal lives.

Entities:  

Mesh:

Year:  1984        PMID: 6693074     DOI: 10.1002/hep.1840040704

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters.

Authors:  Sittisak Honsawek; Voranush Chongsrisawat; Paisarn Vejchapipat; Nutchanart Thawornsuk; Pisit Tangkijvanich; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2004-12-24       Impact factor: 1.827

2.  Experience with laparoscopy for the evaluation of cholestasis in newborns.

Authors:  F Schier; J Waldschmidt
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

3.  Post-operative abdominal CT scanning in extrahepatic biliary atresia.

Authors:  D L Day; P F Mulcahy; L P Dehner; J G Letourneau
Journal:  Pediatr Radiol       Date:  1989

4.  A long-term experience with biliary atresia. Reassessment of prognostic factors.

Authors:  D U Tagge; E P Tagge; R A Drongowski; K T Oldham; A G Coran
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

5.  Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats.

Authors:  Chih-Cheng Chen; Chun-Yi Ho; Hsio-Chi Chaung; You-Lin Tain; Chih-Sung Hsieh; Fang-Ying Kuo; Chun-Yu Yang; Li-Tung Huang
Journal:  Dig Dis Sci       Date:  2012-12-01       Impact factor: 3.199

Review 6.  Liver transplantation: current concepts.

Authors:  W J Wall
Journal:  CMAJ       Date:  1988-07-01       Impact factor: 8.262

7.  Bleeding as the first symptom of extrahepatic biliary atresia.

Authors:  R H Houwen; J Bouquet; C M Bijleveld
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

Review 8.  Biliary atresia.

Authors:  Christophe Chardot
Journal:  Orphanet J Rare Dis       Date:  2006-07-26       Impact factor: 4.123

9.  Newborn biliary atresia screening with the stool colour card: a questionnaire survey of parents.

Authors:  Morgane Borgeat; Simona Korff; Barbara E Wildhaber
Journal:  BMJ Paediatr Open       Date:  2018-05-29

10.  Development and Validation of Novel Diagnostic Models for Biliary Atresia in a Large Cohort of Chinese Patients.

Authors:  Rui Dong; Jingying Jiang; Shouhua Zhang; Zhen Shen; Gong Chen; Yanlei Huang; Yijie Zheng; Shan Zheng
Journal:  EBioMedicine       Date:  2018-08-01       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.